HAIFA, Israel, Dec. 31, 2015 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today announced that the U.S. Food and Drug Administration has granted the … Read the full article on CNNMoney »
U.S. Food & Drug Administration Grants Orphan Drug Designation to Pluristemb - CNNMoney
No comments:
Post a Comment